Skip to main content
. 2019 Oct 24;22(2):267–277. doi: 10.1093/neuonc/noz155

Table 3.

Multivariable analysis including ECM

PFS EGFR/ALK+ NSCLC P Wild Type P
HR (95% CI) HR (95% CI)
Age (<50 vs 50–60 vs >60) 0.81 (0.59, 1.13) 0.21 0.92 (0.74, 1.15) 0.48
KPS (<70 vs 70–80 vs >80) 0.59 (0.38, 0.92) 0.02 0.72 (0.58, 0.90) 0.004
Brain mets (1 vs 2–3 vs >3) 0.93 (0.70, 1.25) 0.65 1.17 (0.98, 1.41) 0.084
Symptomatic 1.06 (0.60, 1.87) 0.84 1.13 (0.79, 1.61) 0.50
Synchronous 0.72 (0.43, 1.18) 0.19 0.78 (0.57, 1.06) 0.11
ECM (yes/no) 0.51 (0.30, 0.87) 0.014 1.41 (1.03, 1.94) 0.031
OS
Age (<50 vs 50–60 vs >60) 1.28 (0.88, 1.88) 0.20 1.06 (0.84, 1.34) 0.62
KPS (<70 vs 70–80 vs >80) 0.35 (0.22, 0.55) <0.001 0.69 (0.54, 0.87) 0.002
Brain mets (1 vs 2–3 vs >3) 0.95 (0.69, 1.31) 0.76 1.20 (0.99, 1.46) 0.063
Symptomatic 0.87 (0.48, 1.60) 0.66 1.09 (0.75, 1.59) 0.65
Synchronous 0.69 (0.40, 1.18) 0.18 0.80 (0.58, 1.11) 0.18
ECM (yes/no) 0.97 (0.54, 1.74) 0.91 1.95 (1.37, 2.77) <0.001